David W. Mudge

Randomized, Controlled Trial of Topical Exit-Site Application of Honey (Medihoney) versus Mupirocin for the Prevention of Catheter-Associated Infections in Hemodialysis Patients

David W. Johnson, Carolyn van Eps, David W. Mudge et al. · Journal of the American Society of Nephrology · 2005 · 161 citations

Catheter Exit Sites, Dialysis Therapy, Topical Exit-site Application +21

Endovascular Proximal Forearm Arteriovenous Fistula for Hemodialysis Access: Results of the Prospective, Multicenter Novel Endovascular Access Trial (NEAT)

Charmaine E. Lok, Dheeraj K. Rajan, Jason Clement et al. · American Journal of Kidney Diseases · 2017 · 139 citations · Full text

Predictors of Decline of Residual Renal Function in New Peritoneal Dialysis Patients

David W. Johnson, David W. Mudge, Joanna M Sturtevant et al. · Peritoneal Dialysis International · 2003 · 133 citations

Metabolic syndrome in severe chronic kidney disease: Prevalence, predictors, prognostic significance and effects of risk factor modification

David W. Johnson, Kirsten A. Armstrong, Scott B. Campbell et al. · Nephrology · 2007 · 117 citations

Free Mycophenolic Acid Should Be Monitored in Renal Transplant Recipients with Hypoalbuminemia

Bronwyn Atcheson, Paul J. Taylor, Carl M. J. Kirkpatrick et al. · Therapeutic Drug Monitoring · 2004 · 112 citations